Conduit Pharmaceuticals has partnered with SARBORG Limited to utilize an advanced artificial intelligence and cybernetics platform aimed at improving various drug development processes, such as drug ...
Neuralink expands trials to 21, advancing brain implants for paralysis and unveiling new cybernetic and Blindsight enhancements.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results